AI & Healthcare News ・ 🩺 Prevention and screening

Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

The Manila Times · 10/24 02:24 UTC

Read the original (The Manila Times)

See it in the digest → ・ See this issue →